Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 99Thoracic 98Gastrointestinal 98Gynecologic 49Genitourinary 30Other solid neoplasm 14Tumor-Agnostic 7CNS 7Endocrine 6Sarcoma 5Breast 5Dermatologic 3Other 2Lymphoid 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1NET 1

Conditions

Gastric Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 3Biopsy 3fludarabine 2Taxes 2Paclitaxel 2Endoscopic Mucosal Resection 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2venetoclax 1trametinib 1toripalimab 1thymoglobulin 1taxane 1sintilimab 1potassium oxonate 1lutetium Lu 177 dotatate 1gimeracil 1fludarabine phosphate 1dabrafenib 1apatinib 1Whole-Body Irradiation 1Watchful Waiting 1Transurethral Resection of Prostate 1Tegafur 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cisplatin × Other neoplasm × Clear all
NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡